Rock Point Advisors Has Lifted Its Popular (BPOP) Position by $727,135; First Mercantile Trust Co Has Decreased Its Ligand Pharmaceuticals (LGND) Position by $360,690; Stock Value Rose

June 16, 2018 - By Stephen Andrade

Popular, Inc. (NASDAQ:BPOP) Logo

Rock Point Advisors Llc increased its stake in Popular (BPOP) by 23.61% based on its latest 2018Q1 regulatory filing with the SEC. Rock Point Advisors Llc bought 17,735 shares as the company’s stock rose 8.86% while stock markets declined. The institutional investor held 92,855 shares of the finance company at the end of 2018Q1, valued at $3.87 million, up from 75,120 at the end of the previous reported quarter. Rock Point Advisors Llc who had been investing in Popular for a number of months, seems to be bullish on the $4.75 billion market cap company. The stock decreased 0.17% or $0.08 during the last trading session, reaching $46.43. About 477,405 shares traded. Popular, Inc. (NASDAQ:BPOP) has risen 22.58% since June 16, 2017 and is uptrending. It has outperformed by 10.01% the S&P500. Some Historical BPOP News: 23/05/2018 – POPULAR INC -AGREEMENT TO TERMINATE ALL SHARED-LOSS AGREEMENTS RELATED TO ACQUISITION OF ASSETS, ASSUMPTION OF CERTAIN LIABILITIES OF WESTERNBANK PUERTO RICO; 04/04/2018 Argentina’s Prisma piques Evertec’s interest; 24/04/2018 – POPULAR 1Q EPS CONT OPS 89C, EST. 78C; 26/04/2018 – S&PGR Affirms Ratings on FirstBank Puerto Rico, OFG Bancorp, Popular Inc; 25/04/2018 – POPULAR INC BPOP.O : CITIGROUP RAISES TARGET PRICE TO $55 FROM $53; 24/04/2018 – Popular 1Q Net $91.3M; 09/05/2018 – Fitch Affirms Popular Inc. at ‘BB-‘ and Removes Negative Watch; Outlook Stable; 19/04/2018 – POPULAR NAMES BETINA CASTELLVI AS CHIEF SECURITY OFFICER; 24/04/2018 – POPULAR INC QUARTERLY NET INTEREST INCOME $393.0 MLN VS $362.1 MLN; 09/04/2018 – Popular Community Bank Changes Name to Popular

First Mercantile Trust Co decreased its stake in Ligand Pharmaceuticals (LGND) by 72.24% based on its latest 2018Q1 regulatory filing with the SEC. First Mercantile Trust Co sold 2,186 shares as the company’s stock rose 24.00% while stock markets declined. The institutional investor held 840 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $139,000, down from 3,026 at the end of the previous reported quarter. First Mercantile Trust Co who had been investing in Ligand Pharmaceuticals for a number of months, seems to be less bullish one the $4.09 billion market cap company. The stock decreased 0.22% or $0.42 during the last trading session, reaching $191.67. About 462,210 shares traded or 37.37% up from the average. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has risen 66.74% since June 16, 2017 and is uptrending. It has outperformed by 54.17% the S&P500. Some Historical LGND News: 20/03/2018 – SPARK’S LUXTURNA GETS FIRST COMMERCIAL USE 3 MOS AFTER FDA OK; 08/05/2018 – LIGAND PHARMA 1Q ADJ EPS $1.55, EST. $1.26; 05/03/2018 Ligand to Participate in Two Upcoming Investor Conferences; 11/04/2018 – ARBUTUS – GENEVANT AIMS FOR 5-10 PRODUCT CANDIDATES INTO CLINIC BY 2020 ACROSS RNAI, MRNA, GENE EDITING MODALITIES USING CO’S LNP, LIGAND CONJUGATE PLATFORMS; 24/05/2018 – Rigenerand Srl | autologous human adipose perivascular stromal cells genetically modified to secrete soluble Tumor Necrosis Factor-related Apoptosis-inducing Ligand (sTRAIL) | N/A | 05/22/2018 | Treatment of Pancreatic Cancer | Designated | NFDA | N/A | | N/A; 07/03/2018 – Top 3 — #1 Metavant makes a debut: Vivek Ramaswamy launches biotech #7 and builds a diabetes pipeline with Ligand deal; 08/05/2018 – LIGAND PHARMACEUTICALS INC – WITH 2018 REVENUE GUIDANCE OF $184 MLN, ADJUSTED EARNINGS PER DILUTED SHARE WOULD BE ABOUT $4.85; 23/05/2018 – BMS-986231 (Bristol-Myers Squibb/Ligand) Drug Overview 2018: A Second-Generation Prodrug That Chemically Breaks Down to Produce Nitroxyl (HNO) and an lnactive Byproduct – ResearchAndMarkets.com; 16/04/2018 – Melinta Therapeutics to Present Detailed Results from Vabomere TANGO Il Trial as well as New In Vitro and In Vivo Findings from Baxdela and Pyrrolocytosine Candidate at ECCMID 2018; 10/05/2018 – Ligand Pharmaceuticals: KSQ Will Be Responsible for All Costs Related to Antibody Development Program

Analysts await Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) to report earnings on August, 6. They expect $0.78 earnings per share, up 44.44% or $0.24 from last year’s $0.54 per share. LGND’s profit will be $16.63M for 61.43 P/E if the $0.78 EPS becomes a reality. After $1.38 actual earnings per share reported by Ligand Pharmaceuticals Incorporated for the previous quarter, Wall Street now forecasts -43.48% negative EPS growth.

Since December 20, 2017, it had 0 buys, and 15 insider sales for $20.78 million activity. On Thursday, February 15 HIGGINS JOHN L sold $1.41M worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 9,000 shares. Sabba Stephen L also sold $112,414 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares. Shares for $536,604 were sold by LAMATTINA JOHN L on Monday, March 5. 8,881 shares were sold by FOEHR MATTHEW W, worth $1.49 million on Thursday, May 10. Davis Todd C sold $2.62M worth of stock. Aryeh Jason sold $529,635 worth of stock.

First Mercantile Trust Co, which manages about $477.65 million US Long portfolio, upped its stake in Aes Corp (NYSE:AES) by 57,944 shares to 125,247 shares, valued at $1.42M in 2018Q1, according to the filing. It also increased its holding in Centerpoint Energy Inc (NYSE:CNP) by 16,601 shares in the quarter, for a total of 31,514 shares, and has risen its stake in Rapid7 Inc.

Among 6 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Ligand Pharmaceuticals had 29 analyst reports since September 3, 2015 according to SRatingsIntel. Roth Capital maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Friday, December 18 with “Buy” rating. The firm earned “Buy” rating on Friday, March 11 by Roth Capital. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has “Buy” rating given on Wednesday, March 7 by Craig Hallum. The company was maintained on Wednesday, October 5 by H.C. Wainwright. H.C. Wainwright reinitiated Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Tuesday, September 5 with “Buy” rating. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, January 24 report. The firm earned “Buy” rating on Monday, September 21 by Roth Capital. On Wednesday, October 11 the stock rating was maintained by Roth Capital with “Buy”. The rating was maintained by Roth Capital on Monday, November 13 with “Buy”. TH Capital maintained the stock with “Buy” rating in Friday, December 18 report.

Investors sentiment decreased to 1.06 in 2018 Q1. Its down 0.19, from 1.25 in 2017Q4. It fall, as 16 investors sold LGND shares while 109 reduced holdings. 52 funds opened positions while 80 raised stakes. 22.56 million shares or 0.54% less from 22.68 million shares in 2017Q4 were reported. Usa Portformulas has invested 0.02% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). State Of Wisconsin Investment Board reported 20,300 shares. Rk Management Ltd reported 1.73% stake. Arizona State Retirement System holds 0.06% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 33,273 shares. Morgan Stanley has invested 0% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Rice Hall James Assoc accumulated 1.96% or 304,692 shares. Ls Investment Advisors Limited Liability reported 0.02% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). 27,247 are held by Janney Montgomery Scott Ltd Liability Co. Tennessee-based State Of Tennessee Treasury Department has invested 0.01% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). State Of Alaska Department Of Revenue reported 6,807 shares stake. Teacher Retirement System Of Texas has invested 0.01% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Ameriprise Financial Inc holds 0.06% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 772,494 shares. Parsons Mgmt Ri holds 0.07% or 3,667 shares in its portfolio. 2,700 were accumulated by Numerixs Investment Tech. Raymond James And Assocs stated it has 15,928 shares.

More recent Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) news were published by: Seekingalpha.com which released: “Ligand Pharmaceuticals (LGND) Presents At Berenberg Conference USA – Slideshow” on May 25, 2018. Also Seekingalpha.com published the news titled: “Xeris Pharmaceuticals on deck for IPO” on May 25, 2018. Nasdaq.com‘s news article titled: “3 Biotech Stocks Up in the Past Month on Industry Turnaround” with publication date: June 15, 2018 was also an interesting one.

More notable recent Popular, Inc. (NASDAQ:BPOP) news were published by: Streetinsider.com which released: “Raising PT’s On BPOP, FBP and OFG On Economic Stability And Hints At Debt Settlement – Piper Jaffray” on May 21, 2018, also Streetinsider.com with their article: “Piper Jaffray Raises Popular (BPOP) PT To $60 On LSA Termination” published on May 29, 2018, Investorplace.com published: “5 Top-Ranked Bank Stocks to Profit From Fed’s Rate Hike” on June 14, 2018. More interesting news about Popular, Inc. (NASDAQ:BPOP) were released by: Businesswire.com and their article: “Popular, Inc. Declares Dividends on Preferred Stock, Announces Distribution on Trust Preferred Securities” published on June 05, 2018 as well as Streetinsider.com‘s news article titled: “Popular (BPOP) to Acquire Wells Fargo’s (WFC) Auto Finance Business in Puerto Rico” with publication date: June 04, 2018.

Investors sentiment increased to 1.33 in Q1 2018. Its up 0.43, from 0.9 in 2017Q4. It improved, as 16 investors sold BPOP shares while 63 reduced holdings. 42 funds opened positions while 63 raised stakes. 88.12 million shares or 2.82% more from 85.70 million shares in 2017Q4 were reported. Sterling Mngmt Lc holds 104,241 shares. Massachusetts Finance Services Ma owns 67,155 shares. Utah Retirement holds 18,709 shares. Moreover, Clinton Gp has 0.3% invested in Popular, Inc. (NASDAQ:BPOP) for 67,931 shares. 15,863 were accumulated by Salzhauer Michael. California Employees Retirement Sys owns 333,256 shares for 0.02% of their portfolio. Manufacturers Life Insur The reported 0% stake. Meeder Asset Management reported 2,391 shares. Denali Advsr Limited Liability has 0.33% invested in Popular, Inc. (NASDAQ:BPOP). Ny State Common Retirement Fund holds 0.02% or 368,200 shares in its portfolio. Sei Investments holds 57,406 shares. Gabelli Funds Limited Com has 38,500 shares. Northern Trust holds 543,938 shares or 0.01% of its portfolio. Financial Bank Of New York Mellon Corp has invested 0.01% in Popular, Inc. (NASDAQ:BPOP). Heartland Advsrs Inc reported 12,311 shares stake.

Popular, Inc. (NASDAQ:BPOP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: